Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Crowther

Showing results (201-210 of 282) with videos related to

Pageof 29
Sort By:
British Journal of Cancer|February 1, 1989
Prognostic factors in high and intermediate grade non-Hodgkin's lymphomaR A Cowan, M Jones, M Harris, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1988
Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancerH Anderson, J Wagstaff, D Crowther, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum (II) (CBDCA) in cancer patientsH Sharma, N Thatcher, J Baer, et al.
British Journal of Cancer|July 29, 1999
Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypesG M Taylor, D A Gokhale, D Crowther, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1991
An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPPM R Ranson, J A Radford, R Swindell, et al.
British Journal of Cancer|March 1, 1977
Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patientR L Powles, J Russell, T A Lister, et al.
British Journal of Cancer|July 1, 1995
Phase II trial of temozolomide in low-grade non-Hodgkin's lymphomaP J Woll, D Crowther, P W Johnson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon alfa-2b in addition to chlorambucil in the treatment of follicular lymphoma: preliminary results of a randomized trial in progressC G Price, A Z Rohatiner, W Steward, et al.
Nuclear Medicine Communications|October 1, 1988
114Inm oxine-labelled lymphocytes--therapeutic applicationsD Hamilton, R A Cowan, M Drayson, et al.
Sarcoma|January 1, 1997
EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue SarcomaH J Keizer, D Crowther, O S Nielsen, et al.
Pageof 29

Showing results (201-210 of 282) with videos related to

Sort By:
Pageof 29
British Journal of Cancer|February 1, 1989
Prognostic factors in high and intermediate grade non-Hodgkin's lymphomaR A Cowan, M Jones, M Harris, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1988
Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancerH Anderson, J Wagstaff, D Crowther, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum (II) (CBDCA) in cancer patientsH Sharma, N Thatcher, J Baer, et al.
British Journal of Cancer|July 29, 1999
Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypesG M Taylor, D A Gokhale, D Crowther, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1991
An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPPM R Ranson, J A Radford, R Swindell, et al.
British Journal of Cancer|March 1, 1977
Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patientR L Powles, J Russell, T A Lister, et al.
British Journal of Cancer|July 1, 1995
Phase II trial of temozolomide in low-grade non-Hodgkin's lymphomaP J Woll, D Crowther, P W Johnson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon alfa-2b in addition to chlorambucil in the treatment of follicular lymphoma: preliminary results of a randomized trial in progressC G Price, A Z Rohatiner, W Steward, et al.
Nuclear Medicine Communications|October 1, 1988
114Inm oxine-labelled lymphocytes--therapeutic applicationsD Hamilton, R A Cowan, M Drayson, et al.
Sarcoma|January 1, 1997
EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue SarcomaH J Keizer, D Crowther, O S Nielsen, et al.
Pageof 29